摘要
目前对阿尔茨海默病(AD)的分子理解尚未导致成功的干预。目前,AD大脑的线粒体功能障碍正成为这种疾病的一个标志。AD中经常影响的一个线粒体功能是氧化磷酸化,负责ATP的产生,也负责活性氧(ROS)的产生和嘧啶的从头合成。本文综述了线粒体产生的活性氧和嘧啶在AD发病机制中的作用及其在大分子氧化变性、必需磷脂合成和维持AD脑线粒体活性中的作用。
关键词: 线粒体,DNA修复,dNTP池,核苷酸代谢,大脑
Current Medicinal Chemistry
Title:The Role of Mitochondrial Dysfunction in the Progression of Alzheimer’s Disease
Volume: 25 Issue: 40
关键词: 线粒体,DNA修复,dNTP池,核苷酸代谢,大脑
摘要: The current molecular understanding of Alzheimer’s disease (AD) has still not resulted in successful interventions. Mitochondrial dysfunction of the AD brain is currently emerging as a hallmark of this disease. One mitochondrial function often affected in AD is oxidative phosphorylation responsible for ATP production, but also for production of reactive oxygen species (ROS) and for the de novo synthesis of pyrimidines. This paper reviews the role of mitochondrial produced ROS and pyrimidines in the aetiology of AD and their proposed role in oxidative degeneration of macromolecules, synthesis of essential phospholipids and maintenance of mitochondrial viability in the AD brain.
Export Options
About this article
Cite this article as:
The Role of Mitochondrial Dysfunction in the Progression of Alzheimer’s Disease, Current Medicinal Chemistry 2018; 25 (40) . https://dx.doi.org/10.2174/0929867324666170616110111
DOI https://dx.doi.org/10.2174/0929867324666170616110111 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Comparative Neurophysiologic Study of Pain in Patients with Parkinson's Disease and Patients with Persistent Pain After Spinal Surgery
Neuroscience and Biomedical Engineering (Discontinued) Current Status and Perspectives in Ceramide-Targeting Molecular Medicine
Current Pharmaceutical Design Changes in Peripheral Blood Biomarkers with Aging and Neurodegenerative Disorders
Current Aging Science Nicotine, Body Weight and Potential Implications in the Treatment of Obesity
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Neuropeptide Systems as Novel Targets for Psychiatric Disorders (Guest Editor: Guy Griebel) ]
CNS & Neurological Disorders - Drug Targets Brain Structural Effects of Antidepressant Treatment in Major Depression
Current Neuropharmacology Adalimumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
Current Neuropharmacology Editorial (Thematic Issue: Neuroinflammation a Common Link in Neurodegenerative Neurological and Psychiatric Disorders)
Current Pharmaceutical Design Association of Prolyl Oligopeptidase with Conventional Neurotransmitters in the Brain
CNS & Neurological Disorders - Drug Targets A Scientometrics Analysis and Visualization of Depressive Disorder
Current Neuropharmacology Rituximab Therapy and Autoimmune Disease
Current Immunology Reviews (Discontinued) NPY Y2 and Y4 Receptors Selective Ligands: Promising Anti-Obesity Drugs?
Current Topics in Medicinal Chemistry Suicide and the Polyamine System
CNS & Neurological Disorders - Drug Targets Altered Amplitude of Low-frequency Fluctuations in Early and Late Mild Cognitive Impairment and Alzheimer's Disease
Current Alzheimer Research Recurrent Pregnancy Losses
Current Women`s Health Reviews Von Willebrand Factor: Drug and Drug Target
Cardiovascular & Hematological Disorders-Drug Targets Harnessing the Natural Pool of Polyketide and Non-ribosomal Peptide Family: A Route Map towards Novel Drug Development
Current Molecular Pharmacology Copy Number Variations with Isolated Fetal Ventriculomegaly
Current Molecular Medicine Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?
Current Cardiology Reviews